SRF and cardiac hypertrophy: Given the importance of miR-1 and miR-133 in various cardiomyopathy developments, such as cardiac hypertrophy, understanding the precise control of SRF-mediated microRNA gene regulation in the heart will provide an additional perspective for the treatment of SRF dysfunction-mediated cardiomyopathy.